<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371373/" ref="ordinalpos=4352&amp;ncbi_uid=4765203&amp;link_uid=PMC3371373" image-link="/pmc/articles/PMC3371373/figure/F1/" class="imagepopup">Fig 1. Potential serotonin receptor-mediated <span class="highlight" style="background-color:">signaling</span> in AD.  From: Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. </a></div><br /><div class="p4l_captionBody">Stimulation of serotonin receptors potentially activates the secondary messenger, cAMP, and subsequently stimulates the PKA-mediated pathway in AD.</div></div>